Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P00750 (
PLA
)
16,800
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Poly(lactic acid) (
PLA
) copolymers having a significantly higher glass transition temperature (T(g)) than that of high molar mass
PLA
homopolymers (typically 60 +/- 5 degrees C) were prepared. Lactic acid was copolymerized with 1,4:3,6-dianhydro-D-glucitol (isosorbide, ISB) and succinic acid (
SA-2
), 1,2,3,4-butanetetracarboxylic acid (BTCA-4) or 1,2,3,4,5,6-cyclohexanehexacarboxylic acid (HCA-6). The highest T(g)s obtained for the copolymers containing BTCA-4 and HCA-6 were 80 and 86 degrees C, respectively. The polymers were prepared by step-growth polymerization in the melt phase, which is an easily operable and simple
PLA
production method in comparison to the ring-opening polymerization (ROP) route. It was shown that the T(g) and the cross-linking induced by the polyfunctional carboxylic acid comonomers could be readily controlled by choosing a suitable polymerization time and temperature. Similar improvement in the T(g) as achieved for the copolymers of BTCA-4 and HCA-6 was not observed for linear copolymers containing ISB and
SA-2
.
...
PMID:Readily controllable step-growth polymerization method for poly(lactic acid) copolymers having a high glass transition temperature. 2034 30